Cancer, gene therapy biotechs raise $303M in IPO bonanza – FierceBiotech
FierceBiotech |
Cancer, gene therapy biotechs raise $303M in IPO bonanza
FierceBiotech Fellow British biotech Nightstar Therapeutics, a gene therapy player working on rare retinal diseases, also got off a $75 million IPO, within the midpoint of the range. After a lackluster biotech IPO market in 2016 and a slow start to this year, public … |
